The Patent Finder

Neela Therapeutics, Inc.

18 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Feb 2033
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 28, 2026
    The maintenance fee for Hippocampal drug delivery devices and methods (US 10,300,251) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
  • 1 fee due Jan 30, 2027
    The maintenance fee for Systems and methods for reducing or preventing backflow in a delivery system (US 10,363,394) comes due Jan 30, 2027. Unpaid by Jul 30, 2027, it lapses early.
  • 1 fee due Mar 10, 2027
    The maintenance fee for Drug delivery systems and methods (US 10,406,285) comes due Mar 10, 2027. Unpaid by Sep 10, 2027, it lapses early.
  • 3 fees due Apr 8 to 29, 2027 · next Apr 8
  • 1 fee due Jun 26, 2027
    The maintenance fee for Therapy specific, pre-programmed auto injection device (US 11,850,374) comes due Jun 26, 2027. Unpaid by Dec 27, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,137,244Microfluidic drug delivery devices with venturi effect
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,434,251Multi-directional microfluidic drug delivery device
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,992,458Systems and Methods for Reducing or Preventing Backflow in a Delivery System
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
US 10,363,394Systems and methods for reducing or preventing backflow in a delivery system
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,456,533Methods and devices for protecting catheter tips and stereotactic fixtures for microcatheters
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,213,653Systems and methods for reducing or preventing backflow in a delivery system
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,065,016Systems and methods for reducing or preventing backflow in a delivery system
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,919,129Systems and Methods for Reducing or Preventing Backflow in a Delivery System
In force
 · High confidence
In forceHigh confidence
US 11,534,592Systems and Methods for Drug Delivery, Treatment, and Monitoring
In force
 · Medium confidence
In forceMedium confidence
US 10,406,285Drug delivery systems and methods
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited